Meningitis charity calls for preventative vaccine to be licensed

Meningitis Research Foundation says the UK Government is in danger of failing millions of families if it doesn’t implement the vaccine.

The Foundation which launched its annual Meningitis Awareness Week today (September 16), has submitted feedback to the committee which advises the UK Government on vaccines. It suggests that the committee’s draft decision not to recommend a vaccine against meningococcal B meningitis and septicaemia (Men B) “at any price” is seriously flawed. The European Commission licensed Bexsero® in January 2013 but individual countries decide whether to use it.  The UK’s Joint Committee on Vaccination and Immunisation (JCVI) cited cost effectiveness and a drop in cases as reasons not to. But Meningitis Research Foundation says basing the decision on the current decline in cases of MenB is short-sighted, as the disease has natural peaks and troughs over the years.  The charity believes the committee has underestimated the prevalence and severity of injury to those affected and ignores long-term damage which consigns children to years of traumatic operations. It also believes it has disregarded common short-term impacts on learning, movement, and psychological well-being. Read more here  
Share page
Print page
Follow us